A multi-institutional randomized phase III trial of chemotherapy alone versus chemotherapy and ablative 5-fraction MRI-guided adaptive radiation therapy for locally advanced pancreatic cancer (LAP-ABLATE)

被引：0
|
作者：
Chuong, Michael D.
Frakes, Jessica M.
Mittauer, Kathryn E.
Good, James
Kim, Josh
Chang, Daniel
Kim, Dae Won
Corradini, Stefanie
Boldrini, Luca
Malafa, Mokenge
O'Reilly, Eileen
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 02期
关键词：
D O I：
10.1158/1538-7445.PANCA2023-A005
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A005
引用
收藏
页数：2
相关论文
共 45 条
  • [11] A randomized phase III multi-institutional study of TNFerade biologic with 5-FU and radiotherapy for locally advanced pancreatic cancer: Final results
    Wild, Aaron Tyler
    Laheru, Dan
    Wang, Hao
    Chang, Kenneth J.
    Taylor, Gretchen Elizabeth
    Donehower, Ross C.
    Pawlik, Timothy M.
    Ziegler, Mark A.
    Cai, Hongyan
    Savage, Dionne T.
    Davis, Yolanda M.
    Klapman, Jason
    Reid, Tony
    Shah, Raj J.
    Wolfgang, Christopher Lee
    Rosemurgy, Alexander
    Herman, Joseph M.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [12] ACTLACC TRIAL: A PHASE III RANDOMIZED TRIAL COMPARING ADJUVANT CHEMOTHERAPY AFTER CONCURRENT CHEMORADIATION VERSUS CONCURRENT CHEMORADIATION ALONE FOR LOCALLY ADVANCED CERVICAL CANCER
    Tangjitgamol, S.
    Tharavichitkul, E.
    Tovanabutra, C.
    Rongsriyam, K.
    Asakij, T.
    Paengchit, K.
    Sukhaboon, J.
    Penpattanagul, S.
    Kridakara, G. C. A.
    Hanprasertpong, J.
    Chomprasert, K.
    Wanglikitkoon, S.
    Atjimakul, T.
    Pariyawateekul, S. L. P.
    Katanyoo, K.
    Tanprasert, P.
    Janweerachai, W.
    Khunnarong, J.
    Srisomboon, J.
    Lorvidhaya, V.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 6 - 7
  • [13] Randomized phase III trial of induction chemotherapy followed by Chemoradiotherapy (CRT) or Chemotherapy (CT) alone for non-resectable Locally Advanced Pancreatic Cancer (LAPC): results of the CONKO-007 trial
    Fietkau, R.
    Ghadimi, M.
    Gruetzmann, R.
    Wittel, U.
    Jacobasch, L.
    Uhl, W.
    Croner, R.
    Bechstein, W.
    Neumann, U.
    Waldschmidt, D.
    Boeck, S.
    Moosmann, N.
    Reinacher-Schick, A.
    Golcher, H.
    Semrau, S.
    Kallies, A.
    Hecht, M.
    Tannapfel, A.
    Oettle, H.
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 11 - 11
  • [14] Surgical outcomes after neoadjuvant ablative dose radiation among patients with borderline resectable and locally advanced pancreas cancer from the multi-institutional phase 2 Stereotactic MR-Guided Adaptive Radiation Therapy (SMART) trial.
    Parikh, Parag
    Asbun, Domenech
    Chuong, Michael David
    Portelance, Lorraine
    Datta, Jashodeep
    Bassetti, Michael F.
    Weber, Sharon M.
    Zaki, Bassem I.
    Smith, Kerrington D.
    Raldow, Ann C.
    Donahue, Timothy R.
    Kim, Hyun
    Hawkins, William G.
    Kelly, Patrick
    Low, Daniel
    Lee, Percy
    Fuss, Martin
    Kwon, David S.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 718 - 718
  • [15] Long-Term Multi-Institutional Outcomes of 5-Fraction Ablative Stereotactic MR-Guided Adaptive Radiation Therapy (SMART) for Inoperable Pancreas Cancer With Median Prescribed Biologically Effective Dose of 100 Gy10
    Chuong, M. D.
    Kirsch, C.
    Herrera, R.
    Rubens, M.
    Gungor, G.
    Schaff, E. M.
    Dolan, J.
    Kim, J.
    Mittauer, K. E.
    Kotecha, R.
    Gutierrez, A.
    Doemer, A. J.
    Ugurluer, G.
    Kwon, D.
    Khan, G.
    Alvarez, D.
    Ucar, A.
    Asbun, H.
    Ozyar, E.
    Parikh, P. J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : S147 - S148
  • [16] Randomized phase III trial of docetaxel and cisplatin combination chemotherapy versus mitomycin, vindesine, and cisplatin combination chemotherapy with concurrent thoracic radiation therapy for locally advanced non-small-cell lung cancer: OLCSG 0007
    Kiura, K.
    Takigawa, N.
    Segawa, Y.
    Kamei, H.
    Takemoto, M.
    Tabata, M.
    Ueoka, H.
    Hiraki, S.
    Matsuo, K.
    Tanimoto, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [17] MRI-guided stereotactic ablative body radiotherapy versus CT-guided percutaneous irreversible electroporation for locally advanced pancreatic cancer (CROSSFIRE): a single-centre, open-label, randomised phase 2 trial
    Timmer, Florentine E. F.
    Geboers, Bart
    Ruarus, Alette H.
    Vroomen, Laurien G. P. H.
    Schouten, Evelien A. C.
    Lei, Susan van der
    Vos, Danielle J. W.
    Dijkstra, Madelon
    Schulz, Hannah H.
    Bakker, Joyce
    Bemd, Bente A. T. van den
    Tol, Petrousjka M. van den
    Puijk, Robbert S.
    Lissenberg-Witte, Birgit, I
    Gruijl, Tanja D. de
    Vries, Jan J. J. de
    Lagerwaard, Frank J.
    Scheffer, Hester J.
    Bruynzeel, Anna M. E.
    Meijerink, Martijn
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2024, 9 (05): : 448 - 459
  • [18] Randomized phase III trial of docetaxel and cisplatin combination chemotherapy versus mitomycin, vindesine and cisplatin combination chemotherapy with concurrent thoracic radiation therapy for locally advanced non-small cell lung cancer: Preliminary report.
    Kiura, K.
    Segawa, Y.
    Tabata, M.
    Takigawa, N.
    Kamei, H.
    Harita, S.
    Ueoka, H.
    Hiraki, S.
    Matsuo, K.
    Tanimoto, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 389S - 389S
  • [19] Preoperative chemoradiotherapy and postoperative chemotherapy with capecitabine and oxaliplatin versus capecitabine alone in locally advanced rectal cancer: First results of the PETACC-6 randomized phase III trial.
    Schmoll, Hans-Joachim
    Haustermans, Karin
    Price, Timothy Jay
    Nordlinger, Bernard
    Hofheinz, Ralf
    Daisne, Jean-Francois
    Janssens, Jozef
    Brenner, Baruch
    Schmidt, Peter
    Reinel, Hans
    Hollerbach, Stephan
    Caca, Karel
    Fauth, Florian W. B.
    Hannig, Carla
    Zalcberg, John Raymond
    Tebbutt, Niall C.
    Mauer, Murielle E.
    Messina, Carlo G. M.
    Lutz, Manfred P.
    Van Cutsem, Eric
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [20] Preoperative chemoradiotherapy and postoperative chemotherapy with 5-fluorouracil and oxaliplatin versus 5-fluorouracil alone in locally advanced rectal cancer: Results of the German CAO/ARO/AIO-04 randomized phase III trial
    Roedel, C.
    Liersch, T.
    Becker, H.
    Fietkau, R.
    Hohenberger, W.
    Hothorn, T.
    Graeven, U.
    Arnold, D.
    Raab, H. -R
    Wittekind, C.
    Staib, L.
    Hess, C.
    Grabenbauer, G.
    Sauer, R.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2014, 190 : 5 - 5
12345